Step 1 topics → Gastrointestinal → IBD Management Overview

IBD Management Overview

USMLE Step 1 trap: Incorrectly extends 5-ASA maintenance therapy from UC to Crohn disease. 5-ASA agents are effective for UC but have limited efficacy in Crohn disease; azathioprine, 6-MP, or biologics are preferred for Crohn maintenance.

IBD management is one of those topics where knowing the disease isn't enough — you have to know what you give, when you give it, and what you screen for before you start. USMLE Step 1 tests this at the level of drug class logic: why a specific agent works for one disease but not the other, and what safety steps are required before initiating immunosuppression. The core framework is induction vs. maintenance, and the exam will absolutely exploit confusion between those two phases.

The trickiest part is that students often apply UC management logic to Crohn disease because both are IBD. That's the trap. Mesalamine (5-ASA) is a mainstay for UC but has poor evidence in Crohn — yet many students confidently select it for Crohn maintenance. Similarly, corticosteroids feel like a natural 'go-to' because they work fast, but Step 1 specifically tests whether you know they are induction-only agents, not maintenance. Using steroids long-term is the wrong answer, every time.

The anti-TNF safety profile is the other high-yield angle. USMLE Step 1 will present a patient about to start infliximab or adalimumab and ask what you do first, or will give a post-initiation complication and ask you to identify it. Latent TB reactivation is the classic example. You need to know the pre-screening checklist cold, and you need to understand why these screens matter mechanistically — TNF is critical for granuloma maintenance, so blocking it can reactivate latent infections that depend on granulomas for containment.

From real student decks
65%have cards covering this topic
41%have mature cards

Common misconceptions

Common mistake
Wrong: 5-ASA agents (mesalamine) are effective maintenance therapy for Crohn disease as they are for UC.
Right: 5-ASA agents are effective for UC but have limited efficacy in Crohn disease; azathioprine, 6-MP, or biologics are preferred for Crohn maintenance.
5-ASA agents like mesalamine work by local anti-inflammatory action on colonic mucosa, which is why they're effective in UC where disease is predominantly colonic and mucosal. Crohn disease is transmural, often involves the small bowel, and has a different inflammatory mechanism — clinical trials have consistently shown 5-ASA agents lack meaningful efficacy for inducing or maintaining remission in Crohn. For Crohn maintenance, think azathioprine, 6-MP, methotrexate, or biologics like infliximab or adalimumab.
Common mistake
Gap: Misses the required pre-biologic screening steps before starting anti-TNF therapy in IBD
Before initiating anti-TNF therapy, patients must be screened for latent TB (PPD/IGRA), hepatitis B, and should be up to date on vaccinations, as anti-TNF agents cause significant immunosuppression.
Anti-TNF agents like infliximab and adalimumab block a cytokine that is essential for maintaining granulomas — the immune structures that wall off latent infections like TB and hepatitis B. If you initiate anti-TNF therapy in a patient with unrecognized latent TB, you disrupt granuloma integrity and can cause fulminant reactivation TB. This is why PPD or IGRA testing, hepatitis B surface antigen and core antibody testing, and vaccination updates (especially live vaccines, which must be given before starting) are all required before the first dose. Skipping this screen is a high-yield wrong answer on Step 1.
Common mistake
Wrong: Corticosteroids are appropriate long-term maintenance therapy for IBD.
Right: Corticosteroids are used only for induction of remission and are not appropriate for maintenance therapy due to cumulative toxicity.
Corticosteroids are effective at rapidly suppressing the acute inflammatory flare in IBD, which makes them excellent induction agents — but they do not alter the underlying disease course and carry serious cumulative toxicity with long-term use (osteoporosis, adrenal suppression, hyperglycemia, infection risk, Cushing features). Because they don't maintain remission and cause harm over time, any answer choice that uses steroids as long-term IBD maintenance therapy is wrong on USMLE Step 1. The correct maintenance agents are aminosalicylates (for UC), immunomodulators, or biologics depending on disease type and severity.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which agents are used for induction of remission versus maintenance of remission in IBD, and understand which drug classes fall into each category (e.g., corticosteroids for induction; azathioprine, 6-MP, biologics for maintenance).
  2. Know what screening is required before starting anti-TNF therapy — specifically latent TB testing (PPD or IGRA), hepatitis B serology, and vaccination status — and understand why each screen matters given the mechanism of immunosuppression.

Can you avoid these mistakes?

A 28-year-old woman with newly diagnosed mild-to-moderate ulcerative colitis is started on mesalamine and achieves remission. What is the appropriate next step in her management — stop therapy, continue mesalamine for maintenance, or transition to azathioprine?
A 34-year-old man with Crohn disease affecting the terminal ileum is in remission after a steroid course. His physician wants to start maintenance therapy. Which agent is most appropriate: mesalamine, prednisone, or azathioprine?
A patient with moderate Crohn disease is about to start infliximab. His IGRA comes back positive but he has no symptoms of active TB. What do you do before initiating infliximab, and why?
A patient with UC has been on oral prednisone for 8 months because 'it keeps their symptoms controlled.' What is wrong with this approach, and what should be done differently?

Related topics

IBD — Ulcerative Colitis vs Crohn Disease Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →